Calgary, Canada

Matthew C Coffey

USPTO Granted Patents = 64 

 

 

Average Co-Inventor Count = 1.9

ph-index = 16

Forward Citations = 658(Granted Patents)

Forward Citations (Not Self Cited) = 346(Dec 10, 2025)


Inventors with similar research interests:


Company Filing History:


Years Active: 2000-2022

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Reoviruses
Viral Purification
Oncolytic Viruses
Neoplastic Cells
Cellular Proliferative Disorders
Ribozymes
Viral Formulations
Virus Clearance
Chemotherapeutic Agents
Proinflammatory Cytokines
Neoplasia
Radiation Therapy
64 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Matthew C Coffey in Biotech

Introduction: Matthew C Coffey, based in Calgary, Canada, is a renowned inventor with an impressive portfolio of 64 patents. His work primarily focuses on the development and modification of reoviruses, which have significant implications for pharmaceutical applications. Coffey's inventions aim to enhance the efficacy of treatments in various medical fields, contributing to the advancement of biotechnology.

Latest Patents: Among his latest patents, Coffey has developed modified reovirus nucleic acid sequences and polypeptide sequences. These reoviruses, designed with specific modifications, promise to revolutionize treatment methods for various diseases. The patents include not only the modified sequences but also pharmaceutical compositions that incorporate these reoviruses, along with methods for their production and usage. This innovative approach highlights Coffey's commitment to improving therapeutic options through intricate biological engineering.

Career Highlights: Coffey's professional journey has been marked by significant contributions to the field of biotechnology. His work at Oncolytics Biotech Inc. and Oncolyties Biotech Inc. showcased his expertise and dedication to advancing cancer treatment methodologies. Through his innovative research, he has played a key role in the development of oncolytic virus therapies.

Collaborations: Throughout his career, Coffey has collaborated with several notable figures in the biotech industry, including coworkers such as Bradley G Thompson and James Strong. These collaborations have further enriched his research and innovation pathways, facilitating the growth of new ideas and inventions within the field.

Conclusion: Matthew C Coffey’s inventive spirit and extensive patent portfolio in the biotechnology sector exemplify the crucial role of innovation in improving medical therapies. His work with modified reoviruses underscores his commitment to advancing treatment options for patients, marking him as a significant contributor to the field of biotech innovations. As the industry continues to evolve, Coffey’s research will undoubtedly play a pivotal role in shaping future therapeutic landscapes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…